The US workforce is facing significant job cuts in June 2025, following widespread layoffs in the first quarter. Reports ...

Donald Trump's 'Big Beautiful bill' will now advance to the Senate. While Republicans defend Medicaid cuts for tax breaks, ...

Three supercharged dividend stocks have the tools and intangibles to fatten investors' pocketbooks in June, and well beyond.

President Trump signed a proclamation on Wednesday to restrict most international students from entering the United States to ...

Neglected tropical diseases (NTDs) are a diverse group of conditions1 that still affect 1 billion people, mainly vulnerable populations in underserved ...

Crews in Baltimore work to contain and clean up a 2,000-gallon diesel fuel spill in Baltimore’s harbor ...

President Donald Trump’s pick to be U.S. surgeon general has said the nation’s medical and food systems are corrupted by ...

Story April 10 - Pfizer: The Big Pharma sold its five-building ... Story March 17 - Merck & Co.: The big pharma is planning to cut 163 jobs at its Cherokee manufacturing plant in Riverside ...

The global CRISPR technology market is expected to witness a growth rate of 16% in the next five years. Continuous ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

The biotech giant that soared during Operation Warp Speed now faces regulatory hurdles, political scepticism, and dwindling ...

The drug candidate, trevogrumab, in combination with Novo Nordisk's popular obesity drug Wegovy, chemically known as semaglutide, helped patients preserve muscle and increase fat loss in patients, ...